TrueTicker

NIFTY 500 › Healthcare

Healthcare · NIFTY 500

Vijaya Diagnostic Centre Ltd.

VIJAYA on NSE · 19 Nov 2026

NIFTY 500

1,510.60 ▼ -1.50 % on the day

Overview Technical Risk & rank Results Accounts Filings Guidance & governance

Guidance tracker

What VIJAYA guided, and what came next

FiledWhat the filing saysNext results: profit YoYRevenueMove on the day
06 Nov 2026Vijaya Diagnostic Centre filed the transcript of its Q2 FY27 earnings call held on November 04, 2026, after its unaudited results for the quarter and half year ended September 30, 2026. Management reported Q2 consolidated revenue of about INR 255 crore, up 26.7% year-on-year, with EBITDA of about INR 113 crore... NSE copy No results filed since
10 Aug 2026Vijaya Diagnostic Centre filed the transcript of its Q1 FY27 earnings conference call held on August 7, 2026, for the quarter ended June 30, 2026. Management reported consolidated revenue of about Rs. 231 crores, up 22.8% year-on-year, with test volume growth of 16.5%; EBITDA of INR 98 crores (margin 42.7%, up 360... NSE copy +37.4 %+26.7 %-1.6 %
06 Aug 2026Vijaya Diagnostic Centre Limited filed its investor presentation on Q1 FY27 (quarter ended June 30, 2026) results, to be used in an earnings call on August 07, 2026 at 10:30 A.M. (IST). Q1 FY27 revenue from operations was INR 2,310 Mn, up 22.8% year on year; EBITDA was INR 985 Mn (42.7% margin); PAT was INR 531 Mn... NSE copy +37.4 %+26.7 %-1.6 %
13 May 2026Transcript of Vijaya Diagnostic Centre's Q4 FY26 earnings call held on May 8, 2026, filed May 13, 2026. Management reported Q4 FY26 consolidated revenue of INR 219 crores, up 26.6% Y-o-Y, with test volume growth of 18.5%; EBITDA of INR 95.5 crores (43.5% margin) and PAT of INR 47.9 crores. For FY26, consolidated... NSE copy +37.6 %+22.8 %-1.4 %
07 May 2026Vijaya Diagnostic Centre Limited filed its investor presentation on Q4 and FY26 financial results (quarter and year ended March 31, 2026), to be used in an earnings call on May 08, 2026 at 2:00 PM IST. Q4 FY26: revenue from operations INR 2,194 Mn, EBITDA INR 955 Mn (43.5% margin), PAT INR 479 Mn (21.8% margin).... NSE copy +37.6 %+22.8 %-1.4 %
19 Feb 2026Vijaya Diagnostic Centre filed the transcript of its Q3 FY26 earnings conference call held on February 13, 2026, after results for the quarter and nine months ended December 31, 2025. Management said consolidated revenue for Q3 FY26 was about INR 205 crores, up 21.4% year-on-year, with EBITDA of about INR 86 crores... NSE copy --+5.9 %
07 Nov 2025Vijaya Diagnostic Centre filed the transcript of its Q2 FY26 earnings conference call held November 04, 2025, following its unaudited results for the quarter and half year ended September 30, 2025. Management (MD & CEO Suprita Reddy) said consolidated revenue for Q2 was Rs.202 crores, up 10.2% year-on-year and 7.2%... NSE copy +22.8 %+21.4 %+2.1 %
02 Aug 2025Vijaya Diagnostic Centre filed the transcript of its Q1 FY'26 earnings conference call held on July 28, 2025, for the quarter ended June 30, 2025. Management (Sunil Reddy) said consolidated revenue was Rs.188 crores, up about 20.4% year-on-year, driven by 17% test volume growth and change in test mix; patient... NSE copy +23.1 %+20.4 %-
15 May 2025Vijaya Diagnostic Centre filed the transcript of its Q4 FY25 earnings conference call held on May 12, 2025, following audited results for the quarter and year ended March 31, 2025. Management said consolidated revenue for Q4 was INR173 crores (up 12%, 13% organic) with EBITDA of INR69 crores (39.8% margin) and PAT... NSE copy +23.1 %+20.4 %-
17 Feb 2025Vijaya Diagnostic Centre filed the transcript of its Q3 FY25 earnings conference call held on February 12, 2025, covering results for the quarter and nine months ended December 31, 2024. Management said consolidated revenue for the quarter was INR 169 crores, up 27% year-on-year, with 20% organic growth excluding... NSE copy +23.1 %+20.4 %-

Filings tagged as guidance, newest first (10 in all), with the company's next results after each: profit and revenue against the same quarter a year before, and the share's move on the results day. Whether the guidance was met is for the reader to judge from both; the site does not score it. The summaries are written by an AI model from the filing and can be wrong - the filing is the source.

Governance

Management, auditors, ratings and legal matters

FiledKindWhat the filing says
03 Nov 2026Management changeBoard of Vijaya Diagnostic Centre Limited met on November 03, 2026 (meeting held 06:12 PM to 06:40 PM IST) and approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, with limited review reports from BSR and Co Chartered Accountants enclosed. The... NSE copy
09 Jul 2026Management changeBoard of Vijaya Diagnostic Centre Limited approved the appointment of Mr. Narasimha Raju K.A. as Chief Financial Officer, effective July 09, 2026. Mr. Narasimha Raju is a Chartered Accountant with over 20 years of experience; he was previously CFO of the Company from March 15, 2021 to March 26, 2025 and most... NSE copy
07 May 2026Management changeBoard outcome for quarter and year ended March 31, 2026: audited standalone and consolidated financial results approved. Final dividend of ₹2 per equity share (200% on face value of ₹1) recommended for FY2025-26, subject to shareholder approval at the AGM; AGM and record dates to be announced later. Dr. D Nageshwar... NSE copy
07 May 2026Management changeBoard meeting outcome dated May 07, 2026: audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 considered and approved. Board recommended a final dividend of ₹2 per equity share (200% on face value of ₹1), subject to shareholder approval at the forthcoming AGM; AGM and... NSE copy
19 Feb 2026Management changeVijaya Diagnostic Centre filed the transcript of its Q3 FY26 earnings conference call held on February 13, 2026, after results for the quarter and nine months ended December 31, 2025. Management said consolidated revenue for Q3 FY26 was about INR 205 crores, up 21.4% year-on-year, with EBITDA of about INR 86 crores... NSE copy
13 Feb 2026Management changeVijaya Diagnostic Centre filed its investor presentation on Q3 and 9M FY26 results (quarter and nine months ended December 31, 2025), for the earnings call on February 13, 2026 at 5:00 PM IST. Q3 FY26: revenue from operations INR 2,052 Mn, EBITDA INR 861 Mn (41.9% margin), PAT INR 432 Mn (21.0% margin); revenue... NSE copy
13 Feb 2026Legal or regulatory, Management changeBoard of Vijaya Diagnostic Centre Limited met on February 13, 2026 and approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (figures not shown in the pages provided). Board appointed Mr. Ravi Shankararamiah and Dr. Sasikala Paruchuri Kola as... NSE copy
04 Nov 2025Legal or regulatoryVijaya Diagnostic Centre filed its investor presentation for Q2 and H1 FY26 results (quarter and half year ended September 30, 2025), for an earnings call on November 04, 2025 at 5:00 PM IST. Q2 FY26: revenue from operations INR 2,016 Mn (10.2% YoY growth), EBITDA INR 818 Mn (40.6% margin), PAT INR 433 Mn (21.5%... NSE copy
04 Nov 2025Legal or regulatoryBoard of Vijaya Diagnostic Centre Limited (Nov 4, 2025) approved unaudited standalone and consolidated results for Q2 and half year ended September 30, 2025, with limited review reports enclosed. NCLT Hyderabad order dated October 13, 2025 sanctioning the amalgamation of Medinova Diagnostic Services Limited into... NSE copy
04 Nov 2025Legal or regulatory, Management changeBoard outcome for quarter and half year ended September 30, 2025: unaudited standalone and consolidated financial results with limited review reports enclosed. NCLT Hyderabad order dated October 13, 2025 sanctioning amalgamation of Medinova Diagnostic Services Limited into Vijaya Diagnostic Centre Limited; scheme... NSE copy
18 Oct 2025Legal or regulatoryVijaya Diagnostic Centre Limited received the certified true copy of the final order dated October 13, 2025 from the NCLT, Hyderabad, approving the Scheme of Amalgamation between Medinova Diagnostic Services Limited (Transferor Company) and Vijaya Diagnostic Centre Limited (Transferee Company). The Effective Date... NSE copy
16 Oct 2025Legal or regulatoryIntimation under Regulation 30 of SEBI Listing Regulations that NCLT Hyderabad Bench pronounced its final order on October 13, 2025 sanctioning the Scheme of Amalgamation of Medinova Diagnostic Services Limited (Transferor Company) into Vijaya Diagnostic Centre Limited (Transferee Company). The order was uploaded... NSE copy
29 Sep 2025Legal or regulatoryVijaya Diagnostic Centre Limited filed an update on the Scheme of Amalgamation of Medinova Diagnostic Services Limited (Transferor Company) with Vijaya Diagnostic Centre Limited (Transferee Company). The NCLT Hyderabad Bench heard the matter on September 26, 2025 and reserved its order on the scheme. The scheme is... NSE copy
28 Jul 2025Management changeVijaya Diagnostic Centre Limited's board met on July 28, 2025 and approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, along with limited review reports. The board granted 2,500 Employee Stock Options under the VDCL Employee Stock Option Plan 2018, convertible... NSE copy
12 May 2025Management changeBoard of Vijaya Diagnostic Centre Limited approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2025, with unmodified audit opinions from statutory auditors. Board recommended a final dividend of ₹2 per equity share (200% on face value of ₹1), subject to shareholder... NSE copy
12 May 2025Management changeBoard of Vijaya Diagnostic Centre Limited, meeting held May 12, 2025, approved audited standalone and consolidated results for the quarter and year ended March 31, 2025, with unmodified audit opinions. The Board recommended a final dividend of ₹2 per equity share (200% on face value of ₹1) for FY2025, subject to... NSE copy
12 Feb 2025Legal or regulatoryVijaya Diagnostic Centre Limited filed its unaudited standalone results for the quarter and nine months ended December 31, 2024, with the limited review report from BSR and Co. Q3 FY25 revenue from operations was Rs. 15,625.54 lakhs and profit for the period was Rs. 3,353.25 lakhs, against Rs. 12,911.78 lakhs... NSE copy
12 Feb 2025Management changeVijaya Diagnostic Centre filed its Q3 & 9M FY25 earnings investor presentation (quarter and nine months ended December 31, 2024), for an earnings call on February 12, 2025 at 05:30 p.m. IST. Q3 FY25 revenue from operations was INR 1,690 Mn (INR 1,580 Mn excluding PH), with EBITDA of INR 671 Mn (39.7% margin) and... NSE copy
12 Feb 2025Legal or regulatoryVijaya Diagnostic Centre Limited filed its unaudited standalone financial results for the quarter and nine months ended December 31, 2024, approved by the Board on February 12, 2025. Q3 FY25 (quarter ended Dec 31, 2024): revenue from operations Rs. 15,625.54 lakhs, profit after tax Rs. 3,353.25 lakhs, basic EPS Rs.... NSE copy

Filings with a management change, a legal or regulatory matter or a credit rating (by their tags), or naming an auditor, a resignation or a pledge of shares; newest first (19 in all). A list of what was filed, not a judgement of the company.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in